Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.

Equity-Insider.com News Commentary – The biotechnology sector is entering a high-stakes survival sprint as major pharmaceutical giants confront a looming $170 ...

The next phase of digital commerce won’t be decided by catalog size or ad reach. It will be won in the narrow window when a ...